{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:18:35Z","timestamp":1791296315396,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.molmed.2011.07.004","type":"journal-article","created":{"date-parts":[[2011,11,29]],"date-time":"2011-11-29T17:57:19Z","timestamp":1322589439000},"page":"707-713","source":"Crossref","is-referenced-by-count":72,"title":["Iron disorders of genetic origin: a changing world"],"prefix":"10.1016","volume":"17","author":[{"given":"Pierre","family":"Brissot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Bardou-Jacquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Jouanolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lor\u00e9al","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2011.07.004_bib0005","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1182\/blood-2011-01-258467","article-title":"Hepcidin and iron regulation, 10 years later","volume":"117","author":"Ganz","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.07.004_bib0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.blre.2008.03.001","article-title":"Current approach to hemochromatosis","volume":"22","author":"Brissot","year":"2008","journal-title":"Blood Rev."},{"key":"10.1016\/j.molmed.2011.07.004_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MOP.0b013e3283425591","article-title":"Inherited disorders of iron metabolism","volume":"23","author":"Camaschella","year":"2011","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.molmed.2011.07.004_bib0020","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1093\/hmg\/ddq165","article-title":"Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches","volume":"19","author":"Schmucker","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.07.004_bib0025","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1182\/blood-2004-09-3468","article-title":"Redox active plasma iron in C282Y\/C282Y hemochromatosis","volume":"105","author":"Le Lan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.07.004_bib0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.gcb.2009.04.004","article-title":"Haemochromatoses. New understanding, new treatments","volume":"33","author":"Brissot","year":"2009","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0035","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00198-008-0701-4","article-title":"Association between iron overload and osteoporosis in patients with hereditary hemochromatosis","volume":"20","author":"Valenti","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.molmed.2011.07.004_bib0040","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s00198-010-1456-2","article-title":"Bone status in a mouse model of genetic hemochromatosis","volume":"22","author":"Guggenbuhl","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.molmed.2011.07.004_bib0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00439-004-1152-4","article-title":"The origin and spread of the HFE-C282Y haemochromatosis mutation","volume":"115","author":"Distante","year":"2004","journal-title":"Hum. Genet."},{"key":"10.1016\/j.molmed.2011.07.004_bib0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0609.2010.01536.x","article-title":"Was the C282Y mutation an Irish Gaelic mutation that the Vikings helped disseminate? HLA haplotype observations of hemochromatosis from the west coast of Sweden","volume":"86","author":"Olsson","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0055","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJMoa041534","article-title":"Hemochromatosis and iron-overload screening in a racially diverse population","volume":"352","author":"Adams","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2011.07.004_bib0060","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1155\/2008\/907356","article-title":"Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening","volume":"22","author":"McLaren","year":"2008","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa073286","article-title":"Iron-overload-related disease in HFE hereditary hemochromatosis","volume":"358","author":"Allen","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2011.07.004_bib0070","series-title":"Haute Autorit\u00e9 de Sant\u00e9","article-title":"French recommendations for management of HFE hemochromatosis","author":"HAS","year":"2005"},{"key":"10.1016\/j.molmed.2011.07.004_bib0075","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1086\/520001","article-title":"Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance","volume":"81","author":"Milet","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2011.07.004_bib0080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0140-6736(04)15436-6","article-title":"Non-invasive assessment of hepatic iron stores by MRI","volume":"363","author":"Gandon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2011.07.004_bib0085","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","article-title":"On T2* magnetic resonance and cardiac iron","volume":"123","author":"Carpenter","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2011.07.004_bib0090","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.3748\/wjg.v13.i35.4755","article-title":"Pathology of hepatic iron overload","volume":"13","author":"Deugnier","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0095","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S1542-3565(05)00607-5","article-title":"Hemochromatosis: genetic testing and clinical practice","volume":"3","author":"Zoller","year":"2005","journal-title":"Clin. Gastroenterol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0100","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3324\/haematol.2010.029751","article-title":"Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants","volume":"96","author":"Aguilar-Martinez","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2011.07.004_bib0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1399-0004.2007.00777.x","article-title":"A novel homozygous frameshift deletion c.471del of HFE associated with hemochromatosis","volume":"71","author":"Cukjati","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.molmed.2011.07.004_bib0110","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1182\/blood-2008-07-167296","article-title":"Homozygous deletion of HFE produces a phenotype similar to the HFE p.C282Y\/p.C282Y genotype","volume":"112","author":"Le Gac","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.07.004_bib0115","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1182\/blood-2008-12-196493","article-title":"Homozygous deletion of HFE: the Sardinian hemochromatosis?","volume":"113","author":"Pelucchi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.07.004_bib0120","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/hmg\/ddg225","article-title":"Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis","volume":"12","author":"Merryweather-Clarke","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.07.004_bib0125","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/hep.23879","article-title":"A phase 1\/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis","volume":"52","author":"Phatak","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2011.07.004_bib0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jhep.2010.08.004","article-title":"Hepcidin in human iron disorders: therapeutic implications","volume":"54","author":"Pietrangelo","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng1274","article-title":"Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis","volume":"36","author":"Papanikolaou","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.07.004_bib0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng1053","article-title":"Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis","volume":"33","author":"Roetto","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.07.004_bib0145","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000321493","article-title":"HJV hemochromatosis, iron overload, and hypogonadism in a Brazilian man: treatment with phlebotomy and deferasirox","volume":"124","author":"Santos","year":"2010","journal-title":"Acta Haematol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood-2009-01-199109","article-title":"Iron overload in the Asian community","volume":"114","author":"Lok","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.07.004_bib0155","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.ejheart.2008.07.012","article-title":"A Q312X mutation in the hemojuvelin gene is associated with cardiomyopathy due to juvenile haemochromatosis","volume":"10","author":"Nagayoshi","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.molmed.2011.07.004_bib0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1399-0004.2009.01261.x","article-title":"Juvenile hemochromatosis due to homozygosity for the G320V mutation in the HJV gene with fatal outcome","volume":"76","author":"Brakensiek","year":"2009","journal-title":"Clin. Genet."},{"key":"10.1016\/j.molmed.2011.07.004_bib0165","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood-2004-09-3508","article-title":"Homozygosity for a novel nonsense mutation (G66X) of the HJV gene causes severe juvenile hemochromatosis with fatal cardiomyopathy","volume":"105","author":"Janosi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.07.004_bib0170","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jhep.2005.06.024","article-title":"Three patients with middle-age-onset hemochromatosis caused by novel mutations in the hemojuvelin gene","volume":"43","author":"Koyama","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3324\/haematol.10701","article-title":"Juvenile hemochromatosis caused by a novel combination of hemojuvelin G320V\/R176C mutations in a 5-year old girl","volume":"92","author":"Aguilar-Martinez","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2011.07.004_bib0180","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bcmd.2005.02.001","article-title":"Juvenile hemochromatosis due to G320V\/Q116X compound heterozygosity of hemojuvelin in an Irish patient","volume":"35","author":"Daraio","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.molmed.2011.07.004_bib0185","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3324\/haematol.2008.001784","article-title":"A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis","volume":"94","author":"Island","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2011.07.004_bib0190","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood-2005-04-1630","article-title":"A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron","volume":"106","author":"Porto","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.07.004_bib0195","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1182\/blood-2004-08-3042","article-title":"Hepcidin is decreased in TFR2 hemochromatosis","volume":"105","author":"Nemeth","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.07.004_bib0200","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2004-04-1416","article-title":"Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis","volume":"105","author":"Kawabata","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.07.004_bib0205","first-page":"302","article-title":"Two novel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis","volume":"90","author":"Koyama","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2011.07.004_bib0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3324\/haematol.11942","article-title":"New TFR2 mutations in young Italian patients with hemochromatosis","volume":"93","author":"Biasiotto","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2011.07.004_bib0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2007.04.014","article-title":"A novel mutation of transferrin receptor 2 in a Taiwanese woman with type 3 hemochromatosis","volume":"47","author":"Hsiao","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0220","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3324\/haematol.13576","article-title":"Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2","volume":"94","author":"Pelucchi","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.molmed.2011.07.004_bib0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000089474","article-title":"Hemochromatosis and severe iron overload associated with compound heterozygosity for TFR2 R455Q and two novel mutations TFR2 R396X and G792R","volume":"115","author":"Lee","year":"2006","journal-title":"Acta Haematol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcmd.2003.08.003","article-title":"The ferroportin disease","volume":"32","author":"Pietrangelo","year":"2004","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.molmed.2011.07.004_bib0235","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1073\/pnas.0503804102","article-title":"The molecular basis of ferroportin-linked hemochromatosis","volume":"102","author":"De Domenico","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.07.004_bib0240","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1053\/j.gastro.2010.12.049","article-title":"Sex and acquired cofactors determine phenotypes of ferroportin disease","volume":"140","author":"Le Lan","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2011.07.004_bib0245","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood-2009-04-216226","article-title":"Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation","volume":"114","author":"Sham","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.07.004_bib0250","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.3748\/wjg.v13.i35.4690","article-title":"Non-HFE haemochromatosis","volume":"13","author":"Wallace","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0255","doi-asserted-by":"crossref","first-page":"C75","DOI":"10.1152\/ajpcell.00621.2008","article-title":"Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype","volume":"298","author":"Wallace","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0260","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bcmd.2007.03.008","article-title":"SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent","volume":"39","author":"Barton","year":"2007","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.molmed.2011.07.004_bib0265","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bcmd.2004.12.002","article-title":"Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features","volume":"34","author":"Sham","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.molmed.2011.07.004_bib0270","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood-2008-03-146134","article-title":"The molecular basis of hepcidin-resistant hereditary hemochromatosis","volume":"114","author":"Fernandes","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.07.004_bib0275","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/sj.emboj.7601735","article-title":"Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin","volume":"26","author":"De Domenico","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2011.07.004_bib0280","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/mds.21938","article-title":"Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability","volume":"23","author":"Fasano","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molmed.2011.07.004_bib0285","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000148691","article-title":"The neurological presentation of ceruloplasmin gene mutations","volume":"60","author":"McNeill","year":"2008","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0290","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jhep.2010.04.039","article-title":"Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation","volume":"53","author":"Finkenstedt","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0295","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1182\/blood-2004-05-1751","article-title":"Molecular characterization of a third case of human atransferrinemia","volume":"104","author":"Knisely","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2011.07.004_bib0300","doi-asserted-by":"crossref","first-page":"G82","DOI":"10.1152\/ajpgi.00538.2010","article-title":"Hypoxia-inducible factor-2{alpha} and iron absorptive gene expression in Belgrade rat intestine","volume":"301","author":"Yeh","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0305","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.exphem.2008.04.014","article-title":"Use of Nramp2-transfected Chinese hamster ovary cells and reticulocytes from mk\/mk mice to study iron transport mechanisms","volume":"36","author":"Zhang","year":"2008","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0310","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpeds.2007.08.041","article-title":"Natural history of recessive inheritance of DMT1 mutations","volume":"152","author":"Iolascon","year":"2008","journal-title":"J. Pediatr."},{"key":"10.1016\/j.molmed.2011.07.004_bib0315","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ng.359","article-title":"Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia","volume":"41","author":"Guernsey","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.07.004_bib0320","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1172\/JCI40372","article-title":"Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts","volume":"120","author":"Ye","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2011.07.004_bib0325","doi-asserted-by":"crossref","first-page":"E1390","DOI":"10.1002\/humu.21243","article-title":"Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA)","volume":"31","author":"De Falco","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2011.07.004_bib0330","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1586\/ehm.10.2","article-title":"Iron-deficiency anemia secondary to mutations in genes controlling hepcidin","volume":"3","author":"Cau","year":"2010","journal-title":"Exp. Rev. Hematol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0335","doi-asserted-by":"crossref","first-page":"750643","DOI":"10.1155\/2010\/750643","article-title":"Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias","volume":"2010","author":"Nemeth","year":"2010","journal-title":"Adv. Hematol."},{"key":"10.1016\/j.molmed.2011.07.004_bib0340","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1586\/erm.10.55","article-title":"Molecular diagnosis of genetic iron-overload disorders","volume":"10","author":"Brissot","year":"2010","journal-title":"Exp. Rev. Mol. Diagn."},{"key":"10.1016\/j.molmed.2011.07.004_bib0345","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/j.gastro.2010.12.037","article-title":"Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation","volume":"140","author":"Brasse-Lagnel","year":"2011","journal-title":"Gastroenterology"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491411001377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491411001377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T02:27:34Z","timestamp":1543372054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491411001377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1471491411001377"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2011.07.004","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}